Whalegun
Home

Biomarin Pharmaceutical BMRN spent $220K on lobbying in Q3 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$220,000
Quarter
Q3 2023
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
23/10/20

Up 4.8% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Biomarin Pharmaceutical's other lobbying reports

Biomarin Pharmaceutical BMRN spent $220K on lobbying in Q3 2023 · Health Issues, Medicare | Whalegun